Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
Extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles constitute the major neuropathological hallmarks of Alzheimer's disease (AD). It is now apparent that parenchymal Aβ plaque deposition precedes behavioral signs of disease by several years. The development of agents...
Guardado en:
Autores principales: | Eric A Tanifum, Indrani Dasgupta, Mayank Srivastava, Rohan C Bhavane, Li Sun, John Berridge, Hoda Pourgarzham, Rashmi Kamath, Gabriela Espinosa, Stephen C Cook, Jason L Eriksen, Ananth Annapragada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ae082d361e647d9ae1ea922315f4efb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
por: Nikisha Carty, et al.
Publicado: (2013) -
Robust light–dark patterns and reduced amyloid load in an Alzheimer’s disease transgenic mouse model
por: Rohan Nagare, et al.
Publicado: (2020) -
Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID
por: Hiroki Sasaguri, et al.
Publicado: (2018) -
VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.
por: Min Song, et al.
Publicado: (2012) -
Diffusion tensor magnetic resonance imaging of the brain in APP transgenic mice: a cohort study.
por: Hans-Peter Müller, et al.
Publicado: (2013)